Search For "clinical"
Clinical trial shows promising new treatment for rare blood cancer
Updated : 5 years, 9 months ago IST
Nagoya [Japan] May 31 (ANI): Scientists have found that chemotherapy combined with drug "rituximab" coupled with treatment for the secondary Central Nervous System (CNS) problem, shows promising results for patients suffering from a rare subtype of Lymphoma (blood cancer).
Read More
Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.
Read More
Study finds women, minorities lacking in research and clinical trials for
Updated : 5 years, 10 months ago IST
Washington D.C. [USA], May 28 (ANI): Over the past decade, women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrolment numbers, finds a recent study.
Read More
Lancet study is not randomised clinical trial, only analysis of hospital r
Updated : 5 years, 10 months ago IST
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
Read More
India disagrees with WHO suspension of HCQ usage, sends letter explaining
Updated : 5 years, 10 months ago IST
New Delhi [India], May 26 (ANI): Health Ministry of India has written to the World Health Organisation (WHO) after the global health body announced to temporarily suspend the clinical trials of Hydroxychloroquine (HCQ) for the treatment of COVID-19 patients, sources told ANI.
Read More
Hydroxychloroquine poses little risk when administered alone in mild cases
Updated : 5 years, 10 months ago IST
New Delhi [India], May 26 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences (AIIMS), New Delhi, on Tuesday said that 'judicious, and appropriate' use of hydroxychloroquine (HCQ) as a standalone drug should not pose any health risks in COVID-19 cases.
Read More
Glenmark to start new phase 3 clinical trial for hospitalised patients of
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Read More
WHO temporarily suspends trial of hydroxychloroquine
Updated : 5 years, 10 months ago IST
Geneva [Switzerland], May 26 (ANI): The World Health Organisation (WHO) on Monday (local time) temporarily suspended the clinical trial of malarial drug hydroxychloroquine for the treatment of coronavirus.
Read More
Combating COVID-19: Novak Djokovic Foundation donates ventilators to hospi
Updated : 5 years, 10 months ago IST
New Delhi [India], May 23 (ANI): As the world continues to grapple with coronavirus pandemic, Serbian tennis star Novak Djokovic's foundation has donated five ventilators and clinical monitors to a general hospital in Krusevac, Serbia.
Read More
COVID-19: India's case mortality per lakh population is 0.2 compared to 4.
Updated : 5 years, 10 months ago IST
New Delhi [India], May 19 (ANI): The Health Ministry said on Tuesday that India has relatively low death figures of COVID-19 cases due to timely case identification and clinical management and the mortality rate is about 0.2 per lakh population compared to 4.1 per lakh population for the wor
Read More
Natco donates Chloroquine for international study to prevent SARS-CoV-2 in
Updated : 5 years, 10 months ago IST
Hyderabad (Telangana) [India], May 19 (ANI): Natco Pharma Ltd said on Tuesday it has donated Chloroquine phosphate tablets through its marketing partner in the United States Rising Pharmaceuticals to support a global clinical trial conducted by the CROWN Collaborative for protecting essentia
Read More
Dr Lal Pathlabs Q4 net profit dips 31 pc to Rs 32.6 crore
Updated : 5 years, 10 months ago IST
New Delhi [India], May 18 (ANI): Diagnostic and healthcare chain Dr Lal Pathlabs on Monday reported 31 per cent decline in its profit after tax in the January to March quarter at Rs 32.6 crore as compared to Rs 47.4 crore in Q4 FY19.
Read More